摘要
Background and aims: Although ticagrelor exerts an antibacterial activity, its effect on infections in patients with ST-segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI) is unclear. We aimed to assess whether ticagrelor and clopidogrel affect infections in these patients during hospitalization. @@@ Methods: A total of 2116 consecutive patients with STEMI undergoing PCI were divided into the ticagrelor (n = 388) and clopidogrel (n = 1728) groups. The primary outcome was infection onset. Secondary outcomes were in-hospital all-cause death and major adverse cardiovascular and cerebrovascular events (MACCE). Propensity score analyses were conducted to test the robustness of the results. @@@ Results: Infections developed in 327 (15.4%) patients. There was no significant difference in infection between both groups (ticagrelor vs. clopidogrel: 13.1% vs. 16.0%, p = 0.164). Patients in the ticagrelor group had lower rates of in-hospital all-cause death and MACCE than patients in the clopidogrel group. Multivariate logistic regression analysis determined that ticagrelor and clopidogrel had a similar preventive effect on infections during hospitalization (adjusted odds ratio [OR] = 1.20; 95% confidence interval [CI] = 0.80-1.78, p = 0.380). Compared to the patients treated with clopidogrel, patients treated with ticagrelor had a slightly lower risk of other outcomes, but no statistical difference. Propensity score analyses demonstrated similar results for infections and other outcomes. @@@ Conclusions: Compared with clopidogrel treatment, ticagrelor treatment did not significantly alter the risk of infections during hospitalization among STEMI patients undergoing PCI, but was associated with a slightly lower risk of in-hospital all-cause death and MACCE.
学科与关键词
- Ticagrelor versus clopidogrel in reducing inflammatory cell infiltration of thrombus aspirated in patients with ST-elevation myocardial infarctionShen, Jing; Liu, Guangzhong; Wu, Guodong; Sheng, Lijian; Cao, Zhengyu; Guo, Shuyuan; Dong, Shaohong; Sun, Xin*; Tian, Ye*European Journal of Clinical Pharmacology, 2022, 78(9): 1391-1398.被引 2
- Association of thrombocytopenia and infection in patients with ST-elevation myocardial infarction undergoing percutaneous coronary interventionWang, Litao; Su, Weijiang; Xue, Jinhua; Gong, Xiao; Dai, Yining; Chen, Jiyan; Xue, Ling; He, Pengcheng; Liu, Yuanhui*; Tan, Ning*BMC Cardiovascular Disorders, 2021, 21(1): 404.被引 2
- Association of Proton Pump Inhibitor and Infection and Major Adverse Clinical Events in Patients With ST-Elevation Myocardial Infarction: A Propensity Score Matching AnalysisLiu, Yuan-Hui; Cao, Zhi-Yuan; Dai, Yi-Ning; Zeng, Li-Huan; Zhang, Ye-Shen; Fan, Hua-Lin; Duan, Chong-Yang; Tan, Ning*; He, Peng-Cheng*Frontiers in Medicine, 2022, 9: 882341.被引 1
